The FDA’s Regulatory Framework for Chimeric Antigen Receptor‐T Cell Therapies
| Main Author: | |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2019-09-01
|
| Series: | Clinical and Translational Science |
| Online Access: | https://doi.org/10.1111/cts.12666 |